About Astellas Pharma India Private Limited
Data last updated:
Astellas Pharma India Private Limited is a foreign private limited company based in Mumbai, Maharashtra, India, a subsidiary of Astellas Pharma Inc. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 November 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85192MH2008FTC188194. Its GSTIN is 27AAHCA3988P1ZT (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹50 Cr and a paid-up capital of ₹33.69 Cr. It is led by directors including Sampada Anandkumar Gosavi (Managing Director) and Mehmet Alp Atay.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2026, the company reported a revenue of ₹123.33 Cr, a growth of 79% compared to the previous year. For the same year it recorded a net profit of ₹7.23 Cr (net margin 5.9%) and EBITDA of ₹10.57 Cr (EBITDA margin 8.6%). Revenue has grown at a compounded annual rate (CAGR) of 59% over three years and 29% over five years.
The company has about 37 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Astellas Pharma. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website astellas.com.
Company details
Contact details
Astellas Pharma India Private Limited's registered office is in Mumbai, Maharashtra. Its website is astellas.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressUnit No. 301 'C & B Square' Cts No. 95 A 127 Andheri Kurla Rd Village Chakala Andhe, Ri (East), Mumbai, Maharashtra, India – 400069
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Astellas Pharma India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Astellas Pharma India operates one associated brand: Astellas Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Generic pharmaceuticals are developed, manufactured, and marketed worldwide. | astellas.com |
Business activity
The main business activity of Astellas Pharma India is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Astellas Pharma India Private Limited, buy the company report.
Financials of Astellas Pharma India Private Limited
FY 2026 filings availableAstellas Pharma India Private Limited reported revenue of ₹123.33 Cr (up 79% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 29% over five years, including 79% growth in the latest year. EBITDA rose 158% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹123.33 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.57 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.23 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.6% | ||||
| Net Profit Margin | 5.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Astellas Pharma India Private Limited, buy the company report.
Board of directors of Astellas Pharma India Private Limited
Astellas Pharma India has 3 current directors and 25 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mehmet Alp Atay | Director | 23 Jul 2020 | 6 Years 3 Months | Current |
| Ricardo Fernando Bezerra Leite | Director | 24 Jan 2024 | 2 Years 9 Months | Current |
| Sampada Anandkumar Gosavi | Managing Director | 24 Mar 2023 | 3 Years 7 Months | Current |
Auditor
Astellas Pharma India Private Limited is audited by S R B C & CO LLP for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S R B C & CO LLP | FY 2026 | 324982E/E300003 |
Shareholding
The shareholding of Astellas Pharma India Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Astellas Pharma India Private Limited, buy the company report.
Legal cases
Astellas Pharma India Private Limited has 1 court case on record: 1 filed by Astellas Pharma India. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Writ petition | Filed by the company against Union of India & Anr. | Pending |
To see the full case history of Astellas Pharma India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Astellas Pharma India Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 5 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier |
To see the full MSME payment records of Astellas Pharma India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Astellas Pharma India Private Limited has a workforce of 37 employees on its EPFO records as of Apr 01, 2024, across 1 active EPFO establishment.
GST
Astellas Pharma India has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCA3988P1ZT | Maharashtra | Active | 01 Jul 2017 |
| 29AAHCA3988P1ZP | Karnataka | Active | 15 Dec 2024 |
To see the full GST registrations and return filing status of Astellas Pharma India Private Limited, buy the company report.
Recent activity
Astellas Pharma India Private Limited has 27 board changes on record since 2009: 3 appointments and 24 cessations. The latest: Ricardo Fernando Bezerra Leite ceased to be Additional Director on 29 Sep 2024.
18 earlier events are in the company report.
News
Frequently asked questions
Astellas Pharma India is an active foreign private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 November 2008 (18+ years old) and is registered under CIN U85192MH2008FTC188194.
Astellas Pharma India has 3 current directors:
- Sampada Anandkumar Gosavi - Managing Director
- Mehmet Alp Atay - Director
- Ricardo Fernando Bezerra Leite - Director
The latest financial statements of Astellas Pharma India on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Astellas Pharma India is 27AAHCA3988P1ZT, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 29AAHCA3988P1ZP (Karnataka).
The CIN (Corporate Identification Number) of Astellas Pharma India is U85192MH2008FTC188194. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Astellas Pharma India has 1 court case on record: 1 filed by the company. 1 is pending.
Astellas Pharma India was incorporated on 14 November 2008, making it 18+ years old. It is registered with the Registrar of Companies, Mumbai.
Ricardo Fernando Bezerra Leite ceased to be Additional Director on 29 Sep 2024. Ricardo Fernando Bezerra Leite was appointed as Director on 24 Jan 2024. Sampada Anandkumar Gosavi was appointed as Managing Director on 24 Mar 2023. Astellas Pharma India has 27 board changes on record in total.
Astellas Pharma India has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 5 overdue payments to 1 micro and small supplier. The latest return was filed on 29 Apr 2024.
Astellas Pharma India can be reached through the website astellas.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Astellas Pharma India is at Unit No. 301 C & B Square Cts No. 95 A 127 Andheri Kurla Rd Village Chakala Andhe, Ri East, Mumbai, Maharashtra, India – 400069.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
